dual sodium/calcium channel blockers (Wyeth)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Namedual sodium/calcium channel blockers (Wyeth)
Drug Alias Namedual sodium/calcium channel blockers (Scion)ion channel blockers (Scion/CeNeS)ion channel blockers (Cambridge NeuroScience)ion channel blockers (Scion)SPI-860
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlutamate [NMDA] receptor antagonistsVoltage-gated N-type calcium channel alpha-1B subunit blockersSodium channels blockers
TargetsVoltage-gated N-type calcium channel alpha-1B subunitGlutamate [NMDA] receptorSodium channels
Therapy Area/IndicationsPainMigraine DisordersEpilepsy +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCeNeS Pharmaceuticals plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesWyeth LlcCeNeS Pharmaceuticals plcFaraday Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPainMigraine DisordersEpilepsy +[4] 

Other Information

ATC CodeN/A
Related LinksN/A